Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Rheumatology International

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00296-010-1379-4PMID 20229030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study.

  2007cited by this paper
• Annexins and Endocytosis

  2007cited by this paper
• International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

  2006influential reference
• Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome.

  2005cited by this paper
• Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.

  2005cited by this paper
• Antiphospholipid antibody tests: spreading the net

  2005cited by this paper
• Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients.

  2004cited by this paper
• Identification of Anti-Plasmin Antibodies in the Antiphospholipid Syndrome That Inhibit Degradation of Fibrin1

  2004cited by this paper
• Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus

  2004cited by this paper
• CEACAM1, a Cell-Cell Adhesion Molecule, Directly Associates with Annexin II in a Three-dimensional Model of Mammary Morphogenesis*

  2003cited by this paper
• Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.

  2003cited by this paper
• The antiphospholipid syndrome.

  2002cited by this paper
• Annexins: from structure to function.

  2002cited by this paper
• The C Terminus of Annexin II Mediates Binding to F-actin*

  2001cited by this paper
• The Role of Annexin II Tetramer in the Activation of Plasminogen*

  1998cited by this paper
• Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study

  1998cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• The management of thrombosis in the antiphospholipid-antibody syndrome.

  1995cited by this paper
• An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II.

  1994cited by this paper
• Annexin II is a major component of fusogenic endosomal vesicles

  1993cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper

• Proteomic profiling of the human amniotic stem cell-highly abundant secreted proteins

  2025cites this paper
• Mechanisms Limiting Renal Tissue Protection and Repair in Glomerulonephritis

  2023influential citation
• Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model

  2021cites this paper
• Autoimmunity to the Lung Protective Phospholipid-Binding Protein Annexin A2 Predicts Mortality Among Hospitalized COVID-19 Patients

  2021influential citation
• Annexin A2 in Fibrinolysis, Inflammation and Fibrosis

  2021influential citation
• Impaired Fibrinolysis in the Antiphospholipid Syndrome

  2021cites this paper
• [Seronegative antiphospholipid syndrome: Myth or reality?]

  2020cites this paper
• Clinical performance of automated chemiluminescent methods for anticardiolipin and anti‐β2‐glycoprotein I antibodies detection in a large cohort of Chinese patients with antiphospholipid syndrome

  2020cites this paper
• Prevalence of anti-S100A10 antibodies in antiphospholipid syndrome patients.

  2019cites this paper
• Rheumatic diseases and autoimmune vascular dementia.

  2017cites this paper
• Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody‐positive patients with adverse clinical outcomes

  2017cites this paper
• Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.

  2017cites this paper
• Dosage de l'annexine A2 au cours du lupus érythémateux systémique

  2017cites this paper
• Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome

  2016cites this paper
• Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis.

  2016cites this paper
• Complement in removal of the dead – balancing inflammation

  2016cites this paper
• Annexin A2, autoimmunity, anxiety and depression.

  2016cites this paper
• TNF-alpha and annexin A2: inflammation in thrombotic primary antiphospholipid syndrome

  2016cites this paper
• Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment.

  2016cites this paper
• Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes

  2016cites this paper
• IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis

  2016cites this paper
• Annexin A2 autoantibodies in thrombosis and autoimmune diseases.

  2015influential citation
• Annexin A2 is a target of autoimmune T and B cell responses associated with synovial fibroblast proliferation in patients with antibiotic-refractory Lyme arthritis.

  2015cites this paper
• Annexin A2 as a target endothelial cell membrane autoantigen in Behçet's disease

  2015cites this paper
• SDF-1(CXCL12) polymorphisms in Egyptian patients with systemic lupus erythematosus (SLE): a pilot study

  2015cites this paper
• The Biology of Annexin A2: From Vascular Fibrinolysis to Innate Immunity.

  2015cites this paper
• Annexin A 2 autoantibodies in thrombosis and autoimmune diseases

  2015cites this paper
• Modulation of the ovarian cancer humoral response by tumor-derived exosomes.

  2014cites this paper
• 20 – Antiphospholipid Syndrome: Pathogenesis, Clinical Presentation, Diagnosis, and Patient Management

  2013cites this paper
• Annexin A2 System in Human Biology: Cell Surface and Beyond

  2013cites this paper
• Antibodies against the N-terminal domain of annexin A2 in antiphospholipid syndrome.

  2012cites this paper
• Differential proteomic analysis of renal tissue in lupus nephritis using iTRAQ reagent technology

  2012cites this paper
• Association of chemokine CXCL12-3′G801A polymorphism with systemic lupus erythematosus in a Han Chinese population

  2012cites this paper
• The Future of Antiphospholipid Antibody Testing

  2012cites this paper
• Annexin A2 and A5 Serve as New Ligands for C1q on Apoptotic Cells*

  2012cites this paper
• Pathogenesis of the Antiphospholipid Syndrome

  2012cites this paper
• The Annexin A2/S100A10 System in Health and Disease: Emerging Paradigms

  2012cites this paper
• Pathophysiology of the antiphospholipid antibody syndrome

  2011cites this paper
• Autoantibodies Against the Fibrinolytic Receptor, Annexin A2, in Cerebral Venous Thrombosis

  2011cites this paper
• and autoantibodies in autoimmune diseases – Insights into SLE, APS and RA: A review

  year unknowncites this paper